IFP Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$324K Buy
3,909
+727
+23% +$60.3K 0.01% 1029
2025
Q1
$258K Sell
3,182
-1,135
-26% -$92.1K 0.01% 1059
2024
Q4
$389K Buy
4,317
+1,747
+68% +$157K 0.01% 831
2024
Q3
$254K Buy
2,570
+688
+37% +$68K 0.01% 978
2024
Q2
$175K Sell
1,882
-928
-33% -$86.1K 0.01% 1108
2024
Q1
$267K Buy
2,810
+255
+10% +$24.2K 0.01% 859
2023
Q4
$228K Sell
2,555
-636
-20% -$56.8K 0.01% 891
2023
Q3
$233K Sell
3,191
-736
-19% -$53.7K 0.01% 899
2023
Q2
$327K Sell
3,927
-60
-2% -$4.99K 0.01% 810
2023
Q1
$385K Sell
3,987
-878
-18% -$84.9K 0.02% 690
2022
Q4
$472K Sell
4,865
-3,063
-39% -$297K 0.01% 914
2022
Q3
$845K Buy
7,928
+613
+8% +$65.3K 0.02% 699
2022
Q2
$787K Hold
7,315
0.03% 658
2022
Q1
$787K Buy
7,315
+5,171
+241% +$556K 0.03% 658
2021
Q4
$240K Buy
2,144
+14
+0.7% +$1.57K ﹤0.01% 858
2021
Q3
$266K Sell
2,130
-1,288
-38% -$161K 0.01% 790
2021
Q2
$462K Buy
3,418
+1,305
+62% +$176K 0.01% 570
2021
Q1
$288K Sell
2,113
-2,073
-50% -$283K 0.01% 689
2020
Q4
$591K Buy
4,186
+571
+16% +$80.6K 0.02% 460
2020
Q3
$400K Buy
3,615
+1,424
+65% +$158K 0.02% 491
2020
Q2
$238K Buy
2,191
+708
+48% +$76.9K 0.02% 605
2020
Q1
$115K Sell
1,483
-160
-10% -$12.4K 0.01% 770
2019
Q4
$156K Sell
1,643
-1,130
-41% -$107K 0.01% 756
2019
Q3
$209K Buy
+2,773
New +$209K 0.01% 754
2019
Q1
$289K Sell
3,203
-4,872
-60% -$440K 0.04% 389
2018
Q4
$566K Sell
8,075
-1,485
-16% -$104K 0.03% 507
2018
Q3
$916K Sell
9,560
-363
-4% -$34.8K 0.04% 456
2018
Q2
$945K Sell
9,923
-19
-0.2% -$1.81K 0.04% 429
2018
Q1
$844K Hold
9,942
0.04% 447
2017
Q4
$844K Sell
9,942
-2,139
-18% -$182K 0.04% 447
2017
Q3
$1.05M Buy
12,081
+1,868
+18% +$162K 0.04% 430
2017
Q2
$788K Buy
10,213
+496
+5% +$38.3K 0.03% 504
2017
Q1
$674K Buy
9,717
+2,892
+42% +$201K 0.03% 552
2016
Q4
$404K Buy
6,825
+2,062
+43% +$122K 0.02% 713
2016
Q3
$316K Buy
4,763
+350
+8% +$23.2K 0.02% 787
2016
Q2
$239K Buy
4,413
+1,210
+38% +$65.5K 0.01% 889
2016
Q1
$289K Buy
3,203
+502
+19% +$45.3K 0.04% 389
2015
Q4
$190K Buy
+2,701
New +$190K 0.01% 850